Jennifer Marie Harris, NP
Nurse Practitioner · Russellville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 12 years
- Graduated 2014
Offices
1 location · St Marys Physician Services LLC · 49 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Jennifer Marie Harris’s office at (479) 968-2345 to ask if they take your plan before you enroll.
Medicaid work
$6,196 in 2021
Medicaid paid $6,196 for 257 billed services this clinician did in 2021, up to 30 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 237 | $5,528 |
| Return visit (30+ min) | 20 | $668 |
| 2021 | 257 | 2 | 30 | $6,196 |
| 2020 | 141 | 4 | 20 | $3,921 |
| 2019 | 121 | 5 | 19 | $2,493 |
| 2018 | 463 | 5 | 20 | $9,758 |
See the largest Medicaid services in earlier years
2020
| Short return visit (20+ min) | 81 | $1,630 |
| Injection, medroxyprogesterone acetate, 1 mg | 22 | $988 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 19 | $652 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 19 | $652 |
2019
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 23 | $616 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 23 | $616 |
| Infectious agent detection by nucleic acid (DNA or RNA); Trichomonas vaginalis, direct probe technique | 25 | $432 |
| Infectious agent detection by nucleic acid (DNA or RNA); Gardnerella vaginalis, direct probe technique | 25 | $428 |
| Infectious agent detection by nucleic acid (DNA or RNA); Candida species, direct probe technique | 25 | $401 |
2018
| Infectious agent detection by nucleic acid (DNA or RNA); Trichomonas vaginalis, direct probe technique | 113 | $2,035 |
| Infectious agent detection by nucleic acid (DNA or RNA); Gardnerella vaginalis, direct probe technique | 113 | $2,010 |
| Infectious agent detection by nucleic acid (DNA or RNA); Candida species, direct probe technique | 113 | $1,990 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 62 | $1,861 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 62 | $1,861 |
Drugs they prescribed that Part D paid
$76,663
Pharmacies billed $76,663 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 394) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
317 generic and fewer than 11 brand-name prescriptions · $76,663 in drug cost · 19 antibiotic prescriptions to 15 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Wegovy | 18 | $28,912 | $1,606 |
| Mounjaro | 16 | $15,036 | $940 |
| Veozah | 12 | $8,677 | $723 |
| Estradiol | 68 | $3,906 | $57 |
| Slynd | 11 | $3,119 | $284 |
See all 9 drugs
| Wegovy | 18 | $28,912 | $1,606 |
| Mounjaro | 16 | $15,036 | $940 |
| Veozah | 12 | $8,677 | $723 |
| Estradiol | 68 | $3,906 | $57 |
| Slynd | 11 | $3,119 | $284 |
| Progesterone | 79 | $2,850 | $36 |
| Estradiol (Twice Weekly) | 28 | $1,805 | $64 |
| Ondansetron Odt | 20 | $172 | $9 |
| Nitrofurantoin Mono-Macro | 11 | $115 | $10 |
Year by year
| 2024 | 394 | 105 | 0% (0) | None | $76,663 |
| 2023 | 393 | 100 | 0% (0) | 54% | $234,876 |
| 2022 | 283 | 88 | 0% (0) | None | $91,836 |
| 2021 | 607 | 173 | None | None | $32,189 |
| 2020 | 375 | 124 | None | 9% | $19,453 |
| 2019 | 183 | 72 | 0% (0) | None | $14,068 |
| 2018 | 155 | 55 | 0% (0) | 19% | $9,487 |
| 2017 | 176 | 58 | 0% (0) | 16% | $11,208 |
| 2016 | 122 | 50 | None | 15% | $6,207 |
| 2015 | 64 | 23 | 0% (0) | None | $2,939 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Mounjaro | 88 | $118,293 | $1,344 |
| Ozempic | 44 | $45,909 | $1,043 |
| Trulicity | 46 | $45,645 | $992 |
| Progesterone | 46 | $2,588 | $56 |
| Estradiol | 31 | $2,173 | $70 |
| Estradiol (Twice Weekly) | 14 | $1,003 | $72 |
| Ondansetron Odt | 18 | $264 | $15 |
| Finasteride | 11 | $71 | $6 |
2022: 4 drugs
| Ozempic | 54 | $51,511 | $954 |
| Mounjaro | 16 | $16,828 | $1,052 |
| Progesterone | 38 | $2,639 | $69 |
| Estradiol | 13 | $1,217 | $94 |
2021: 12 drugs
| Estradiol | 27 | $2,439 | $90 |
| Progesterone | 17 | $1,006 | $59 |
| Levothyroxine | 39 | $956 | $25 |
| Nitrofurantoin Mono-Macro | 20 | $442 | $22 |
| Omeprazole | 16 | $416 | $26 |
| Montelukast | 18 | $373 | $21 |
| Nitrofurantoin | 17 | $334 | $20 |
| Lisinopril | 21 | $172 | $8 |
| Citalopram Hbr | 13 | $154 | $12 |
| Atorvastatin | 13 | $123 | $9 |
| Zolpidem | 14 | $120 | $9 |
| Sulfamethoxazole-Trimethoprim | 12 | $42 | $4 |
2020: 8 drugs
| Estradiol | 57 | $5,681 | $100 |
| Progesterone | 20 | $1,001 | $50 |
| Venlafaxine Hcl Er | 20 | $442 | $22 |
| Liothyronine | 13 | $338 | $26 |
| Nitrofurantoin Mono-Macro | 18 | $329 | $18 |
| NP Thyroid | 16 | $308 | $19 |
| Sprintec | 14 | $263 | $19 |
| Sulfamethoxazole-Trimethoprim | 15 | $60 | $4 |
2019: 2 drugs
| Estradiol | 69 | $5,429 | $79 |
| Metronidazole | 16 | $347 | $22 |
2018: 2 drugs
| Estradiol | 49 | $2,598 | $53 |
| Metronidazole | 12 | $159 | $13 |
2017: 3 drugs
| Estrace | 13 | $3,779 | $291 |
| Estradiol | 54 | $1,076 | $20 |
| Norgestimate-Ethinyl Estradiol | 11 | $114 | $10 |
2016: 2 drugs
| Estradiol | 53 | $1,202 | $23 |
| Metronidazole | 11 | $489 | $44 |
2015: 2 drugs
| Estradiol | 20 | $620 | $31 |
| Alendronate | 15 | $75 | $5 |
Money from drug and device companies
$1,150 in 2025
| 2025 | 4 | 6 | $1,070 | $1,150 |
| 2024 | 11 | 41 | $6,919 | $8,598 |
| 2023 | 9 | 33 | $5,941 | $7,285 |
| 2022 | 12 | 32 | $2,922 | $4,727 |
| 2021 | 2 | 11 | None | $264 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Wegovy | $1,070 | 2 payments
|
| Shield Therapeutics | Accrufer | $38 | 2 payments
|
| Abbvie | Vraylar | $25 | 1 payment
|
| Sagent Pharmaceuticals | Glydo | $17 | 1 payment
|
See all 6 published payments
| Sagent Pharmaceuticals | Meals · 2025-12-09 | Glydo | $17 |
| Novo Nordisk | Paid to speak or teach · 2025-06-25 | Wegovy | $394 |
| Abbvie | Meals · 2025-02-05 | Vraylar | $25 |
| Shield Therapeutics | Meals · 2025-01-02 | Accrufer | $19 |
| Shield Therapeutics | Meals · 2025-01-02 | Accrufer | $19 |
| Novo Nordisk | Paid to speak or teach · 2025-01-01 | Wegovy | $676 |
See earlier years (2024, 2023, 2022, 2021)
2024: $8,598
| Novo Nordisk | Wegovy | $8,239 | 18 payments
|
| Shield Therapeutics | Accrufer | $153 | 12 payments
|
| Biogen | Zurzuvae | $36 | 2 payments
|
| Astellas Pharma US | Veozah | $32 | 2 payments
|
| Abbott Laboratories | Cardiomems | $29 | 1 payment
|
| Lilly USA | Zepbound | $21 | 1 payment
|
| Organon | Nexplanon | $20 | 1 payment
|
| Becton Dickinson and | Bd Onclarity | $20 | 1 payment
|
| Hologic Sales and Service | Thinprep 2000 Processor | $17 | 1 payment
|
| Sumitomo Pharma America | Myfembree | $16 | 1 payment
|
| Minerva Surgical | None | $14 | 1 payment
|
2023: $7,285
| Novo Nordisk | Wegovy | $6,115 | 17 payments
|
| Abbott Laboratories | Cardiomems | $943 | 7 payments
|
| Hologic Sales and Service | Novasure | $67 | 1 payment
|
| Myriad Women's Health | Myrisk | $53 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Mirena | $34 | 2 payments
|
| Lilly USA | Mounjaro | $28 | 2 payments
|
| Astellas Pharma US | Veozah | $18 | 1 payment
|
| Pfizer | Premarin | $16 | 1 payment
|
| Mayne Pharma Commercial | Nextstellis | $11 | 1 payment
|
2022: $4,727
| Novo Nordisk | Saxenda | $4,314 | 16 payments
|
| Abbott Laboratories | Confirm Rx | $143 | 2 payments
|
| Mayne Pharma | None | $64 | 3 payments
|
| Abbvie | Oriahnn | $45 | 2 payments
|
| Lilly USA | Mounjaro | $30 | 2 payments
|
| Myovant Sciences | Myfembree | $30 | 1 payment
|
| Becton Dickinson and | Bd Onclarity | $29 | 1 payment
|
| Organon | Nexplanon | $16 | 1 payment
|
| Pfizer | Premarin | $15 | 1 payment
|
| Hologic | Novasure | $15 | 1 payment
|
| TherapeuticsMD | Annovera | $14 | 1 payment
|
| Lundbeck | Abilify Maintena | $12 | 1 payment
|
2021: $264
| Novo Nordisk | Wegovy | $215 | 8 payments
|
| Abbott Laboratories | Confirm Rx | $49 | 3 payments
|
Professional record
- NPI
- 1588053789
- Licence
- AR A004265
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- Po Box 10054, Russellville, AR, 72812
- NPI first listed
- 2015-01-12
- NPI last updated
- 2026-04-10
- NPI record certified
- 2026-04-10
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 721 Depot Dr, Anchorage, AK, 99501 · 999 18th St Ste 3000, Denver, CO, 80202 · 112 Maverick Ct, Granbury, TX, 76049 · 400 W Capitol Ave Ste 1700, Little Rock, AR, 72201 · 5600 N May Ave Ste 310, Oklahoma City, OK, 73112 · 195 Page Mill Rd Ste 103, Palo Alto, CA, 94306 · Po Box 10054, Russellville, AR, 72812 · 173 Saint Patricks Dr Ste 104, Waldorf, MD, 20603